Anti-HIV1 p55 + p17 antibody
英文名称 | HIV1 p55 + p17 |
中文名称 | 艾滋病病毒p55/p17抗体 |
别 名 | HIV1 p17; HIV1 p55; Gag; Gag polyprotein; Pr55; Pr55Gag; HIV1 Pr55Gag; Human immunodeficiency virus 1 p55; HIV1 p55+p17; HIV1 matrix protein p17; MA; Matrix protein; Matrix protein p17; Human immunodeficiency virus 1 p17; Human immunodeficiency virus type 1 p24; Capsid protein p24; CA; Spacer peptide p2; Nucleocapsid protein p7; NC; Spacer peptide p1; p6-gag. |
DATASHEET
Host:Rabbit
Target Protein:HIV1 p55 + p17
IR:Immunogen Range:76-170/497
Clonality:Polyclonal
Isotype:IgG
Entrez Gene:155030
Swiss Prot:N/A
Source:KLH conjugated synthetic peptide derived from HIV1 p55/p17:76-170/497
Purification:affinity purified by Protein A
Storage:0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. Shipped at 4℃. Store at -20 °C for one year. Avoid repeated freeze/thaw cycles.
Background:HIV1 performs highly complex orchestrated tasks during the assembly, budding, maturation and infection stages of the viral replication cycle. During viral assembly, the proteins form membrane associations and self-associations that ultimately result in budding of an immature virion from the infected cell. Gag precursors also function during viral assembly to selectively bind and package two plus strands of genomic RNA. p55 is digested by HIV1 protease into intermediate products p41 and p15. p41 is further digested into matrix protein p17 and capsid protein p24. Likewise, p15 is further digested into nucleocapsid protein p7 and to p6 and p1.
Size:100ul
Concentration:1mg/ml
Applications:ELISA(1:5000-10000)
IHC-P(1:100-500)
IHC-F(1:100-500)
IF(1:50-200)
Cross Reactive Species:HIV.
For research use only. Not intended for diagnostic or therapeutic use.
好评度